Efficacy and Safety of Harvoni (Ledipasvir/Sofosbuvir) in HCV Treatment in a Community Setting

被引：0
|
作者：
Abdullah, Khalid [1 ]
Dawood, Hasan [1 ]
Ortiz, Herman [1 ]
Zela, Scott [1 ]
Egwim, Chukwuma [1 ]
Ankoma-Sey, Victor [1 ]
机构：
[1] Liver Associates Texas PA, Houston, TX USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2017年 / 112卷
关键词：
D O I：
10.14309/00000434-201710001-01012
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1011
引用
收藏
页码：S564 / S565
页数：2
相关论文
共 50 条
  • [11] Safety and efficacy of sofosbuvir/ledipasvir and sofosbuvir/daclatasvir in the treatment of hepatitis C in patients with decompensated cirrhosis
    El Kassas, Mohamed
    Abdeen, Nermeen
    Omran, Dalia
    Alboraie, Mohamed
    Salaheldin, Mohamed
    Eltabbakh, Mohamed
    Farghaly, Rasha
    Emadeldeen, Mohammed
    Afify, Shimaa
    Sweedy, Ahmad
    Ghalwash, Ahmed
    Abbass, Amr
    Ezzat, Sameera
    Tahoon, Marwa
    ELshazly, Helmy M.
    Hamdy, Hassan
    Omar, Heba
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 : E877 - E882
  • [12] Safety and efficacy of sofosbuvir/ledipasvir and sofosbuvir/daclatasvir in the treatment of hepatitis C in patients with decompensated cirrhosis
    El Kassas, Mohamed
    Abdeen, Nermeen
    Omran, Dalia
    Alboraie, Mohamed
    Salaheldin, Mohamed
    Eltabbakh, Mohamed
    Farghaly, Rasha
    Emadeldeen, Mohammed
    Afify, Shimaa
    Sweedy, Ahmad
    Ghalwash, Ahmed
    Abbass, Amr
    Ezzat, Sameera
    Tahoon, Marwa
    ELshazly, Helmy M.
    Hamdy, Hassan
    Omar, Heba
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) : E877 - E882
  • [13] Sofosbuvir/ledipasvir safety and efficacy for HCV patients with haemodialysis and liver cirrhosis: a small retrospective study
    Ebtisam Boushi
    Khaled Cheha
    Noha Hedar
    Rasha Almokdad
    Mohammed Waleed Alassi
    Ameer Kakaje
    Egyptian Liver Journal, 11
  • [14] Drug Authorization for Sofosbuvir/Ledipasvir (Harvoni) for Chronic HCV Infection in a Real-World Cohort: A New Barrier in the HCV Care Cascade
    Do, Albert
    Mittal, Yash
    Liapakis, AnnMarie
    Cohen, Elizabeth
    Chau, Hong
    Bertuccio, Claudia
    Sapir, Dana
    Wright, Jessica
    Eggers, Carol
    Drozd, Kristine
    Ciarleglio, Maria
    Deng, Yanhong
    Lim, Joseph K.
    PLOS ONE, 2015, 10 (08):
  • [15] Sofosbuvir/ledipasvir safety and efficacy for HCV patients with haemodialysis and liver cirrhosis: a small retrospective study
    Boushi, Ebtisam
    Cheha, Khaled
    Hedar, Noha
    Almokdad, Rasha
    Alassi, Mohammed Waleed
    Kakaje, Ameer
    EGYPTIAN LIVER JOURNAL, 2021, 11 (01)
  • [16] Efficacy of sofosbuvir and ledipasvir in an HCV plus gastro-resected patient
    Taibi, C.
    Tempestilli, M.
    D'Avolio, A.
    Garbuglia, A. R.
    De Nicolo, A.
    Montalbano, M.
    D'Offizi, G.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2017, 42 (05) : 621 - 623
  • [17] Safety and Efficacy of Ledipasvir/Sofosbuvir without on-Treatment Laboratory Monitoring in HCV-Infected Rwandans: The Shared 2 Study
    Grant, Philip
    Kabahizi, Jules
    Mbituyumuremyi, Aimable
    Van Nuil, Jennifer Ilo
    Mukabatsinda, Constance
    Damascene, Makuza Jean
    Shumbusho, Fabienne
    Ntirenganya, Cyprien
    Nsanzimana, Sabin
    Gupta, Neil
    HEPATOLOGY, 2018, 68 : 36A - 36A
  • [18] Safety and Efficacy of Ledipasvir/Sofosbuvir on Hepatitis C Eradication in HCV/HIV Co-infected Patients
    He, Xiaoping
    Hopkins, Lynne
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S1497 - S1498
  • [19] Postmarketing Safety Profile of Ledipasvir/Sofosbuvir Chronic HCV Infection Therapy
    Ali, Ayad K.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2016, 25 : 433 - 434
  • [20] Ventricular Tachycardia as a Complication of Ledipasvir and Sofosbuvir Treatment for HCV Infection
    Nirei, Kazushige
    Nakamura, Hitomi
    Matsuoka, Shunichi
    Yamana, Yoichiro
    Yoda, Shunichi
    Hirayama, Atsushi
    Moriyama, Mitsuhiko
    INTERNAL MEDICINE, 2017, 56 (07) : 787 - 790
12345